Cube Biotech appoints Michael Bencak as new CEO amid global expansion plans

Ella Day | July 25, 2025 | Appointment | Mergers and Acquisitions, Research and Development CEO, Corporate, Cube Biotech, IBA Lifescience, archimed, executive chairman 

Cube Biotech has announced a leadership transition as the company continues its trajectory of global growth and innovation in protein research. Didier Dargent, who has served as chief executive officer (CEO), will assume the role of executive chairman. Michael Bencak, an experienced biotech executive, has been appointed as the new CEO of both Cube Biotech and IBA Lifescience, effective immediately.

Dargent commented: “It’s been an incredible journey leading Cube Biotech and I’m proud of what we’ve achieved. As I take on the role of executive chairman, I’m confident in Michael’s ability to guide the company into its next phase.”

Bencak brings a strong background in leading life sciences companies through growth and transformation. “What inspired me to join is not only the science, but the passion, purpose and ambition behind it,” he said. “I truly believe we have the chance to make a meaningful difference.”

Advertisement

Based in Germany, Cube Biotech is a specialist in protein purification, stabilisation and screening. The company’s recent merger with IBA Lifescience, backed by healthcare investor ARCHIMED, has strengthened its position as a partner in drug discovery.

Its most recent automation technology enables scalable membrane protein production, streamlining structural biology and therapeutic development workflows for researchers.

Ella Day
25/7/25

Related Content

5997920696_ecb224068e_b

CEO of PixarBio Corporation sentenced to prison for defrauding investors

Frank Reynolds, the CEO of Boston based PixarBio Corporation, was sentenced to seven years in …

thomas-neff

FibroGen rocked by unexpected death of CEO Thomas B Neff

In a saddening turn of events, San Francisco-based FibroGen has announced that Thomas B Neff, …

allergan

Allergan shareholders reject proposal to split roles of chairman and CEO

Allergan shareholders have rejected a proposal to immediately separate the roles of CEO and chairman, …

The Gateway to Local Adoption Series

Latest content